Bernard Rivers
Global Fund and Others Announce Cheaper Drug Possibilities for Grant Recipients
The Global Fund and three other organizations today announced ways in which grant recipients can obtain high quality antiretroviral drugs and diagnostics at very low prices that previously were only available to a few countries. The press statement by the four organizations is reproduced below, together with a supporting “Question and Answer” document. This article is based in part upon…
Plans Are Fine, But Who Has Been Helped?
In the past few years we have heard many announcements – such as today’s – about scaling up plans and programs regarding HIV/AIDS treatment. They have come from UNAIDS, WHO, PAHO and the Global Fund, as well as generic and originator drug companies. But after the press coverage dies down, things don’t seem to change very much for the people…
The Press Release Announcing the Pricing Agreement
[The following press release was issued on 6 April 2004 by the William J. Clinton Foundation, The Global Fund, UNICEF, and The World Bank.] 6 April 2004 New Agreements Aim to Make Lowest-Priced AIDS Drugs and Diagnostics Available to Hundreds of Thousands of Patients Throughout the Developing World Global Fund, World Bank and UNICEF join with the Clinton Foundation to…
Further Details Regarding Pricing Agreement, Released by the Four Participants
[The following Q&A regarding the pricing agreement was released on 6 April 2004 by the same four organizations as the above press release.] Questions & Answers Governments and nongovernmental organizations (NGOs) purchase the drugs and diagnostics or outsource this task to procurement agents, such as UNICEF. In some cases as in South Africa or China, the governments use their own…
New York Times on AIDS
Bernard Rivers
Highlights
Bernard Rivers
Board Decisions Regarding the Approving of Grants
Bernard Rivers
